Article

PEG-INF ALFA-2B (ALGERON) VA TENOFOVIR ALAFENAMID (TAF) KOMBINATSIYASINING SURUNKALI DELTA GEPATITNI DAVOLASHDAGI SAMARADORLIGINI BAHOLASH

Raimov Kamol Eshmo'minovichToshkent davlat tibbiyot universiteti Termiz filiali assistenti. Termez

Zenodo (CERN European Organization for Nuclear Research)repository2025

ABI

Abstract

Surunkali delta gepatit (SDG) – gepatit B virusi (HBV) bilan birgalikda yuquvchi kasallik bo‘lib, jigar to‘qimasida og‘ir yallig‘lanish va fibroz jarayonlarini keltirib chiqaradigan kasallikdir. SDG dunyo bo‘yicha gepatitlar orasida eng xavfli va davolashda murakkab bo‘lgan turlaridan biri hisoblanadi

Topics

Viral gastroenteritis research and epidemiology Membrane Separation Technologies Bacteriophages and microbial interactions

Identifiers

DOI: 10.5281/zenodo.17684894

Citations and references

Cited by 00 references

Metrics — AkademScholar